SCHEMBL24378580

SCHEMBL24378580

CC1O[C@@H](C)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@H]1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 2/20 0.50
MTOR P42345 1/20 0.50
SSTR1 P30872 1/20 0.42
SSTR2 P30874 1/20 0.42
SSTR4 P31391 1/20 0.42
SSTR3 P32745 1/20 0.42
SSTR5 P35346 1/20 0.42
TSHR P16473 1/20 0.41
BCHE P06276 3/20 0.40
ACHE P22303 2/20 0.40
IDO1 P14902 1/20 0.39
TACR1 P25103 2/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
CTSK P43235 1/20 0.38
AGXT P21549 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18573748 1.00 PDPK1 (0.50) PDPK1MTORSSTR1SSTR2SSTR4
SCHEMBL24378475 1.00 PDPK1 (0.50) PDPK1MTORSSTR1SSTR2SSTR4
SCHEMBL14413414 1.00 PDPK1 (0.50) PDPK1MTORSSTR1SSTR2SSTR4
SCHEMBL24378456 0.98 PDPK1 (0.47) PDPK1MTORSSTR1SSTR2SSTR4
SCHEMBL13129890 0.91 PDPK1 (0.46) PDPK1MTORSSTR1SSTR2SSTR4
SCHEMBL19726196 0.91 PDPK1 (0.46) PDPK1MTORSSTR1SSTR2SSTR4
SCHEMBL13129788 0.91 PDPK1 (0.46) PDPK1MTORSSTR1SSTR2SSTR4
SCHEMBL13129923 0.91 PDPK1 (0.46) PDPK1MTORSSTR1SSTR2SSTR4
SCHEMBL13129892 0.91 PDPK1 (0.46) PDPK1MTORSSTR1SSTR2SSTR4
SCHEMBL7775231 0.90 PDPK1 (0.45) PDPK1MTORSSTR1SSTR2SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127239-A1 GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF SICHUAN UNIVERSITY (CN) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127239-A1 GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF UGGT1, ALG8, FUT6 PDPK1 2443/4885MTOR 1813/4885SSTR1 4226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.